NeoSync Overview

  • Founded
  • 2008
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

NeoSync General Information

Description

Developer of personalized therapies designed to treat major mental depressions. The company's therapies use Transcranial Magnetic Stimulation (TMS) which is a non-invasive form of brain stimulation that delivers low energy, alternating magnetic field stimulation in daily 30 minute sessions to gently adjust a depressed brain toward a more normal state, enabling patients to cure major depressive disorders and other diseases of the central nervous system quickly.

Contact Information

Website
www.neosync.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Other Healthcare Technology Systems
Acquirer
Primary Office
  • 800 West Cummings Park
  • Suite 2650
  • Woburn, MA 01801
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NeoSync Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 26-Feb-2020 000.00 Completed Generating Revenue
6. Later Stage VC (Series D) 10-Aug-2017 0000 000.00 Completed Clinical Trials - Phase 3
5. Later Stage VC (Series C) 01-Jan-2016 000.00 000.00 000.00 Completed Startup
4. Later Stage VC (Series C) 21-Jun-2010 00.000 00.000 0000 Completed Startup
3. Early Stage VC (Series B) 10-Mar-2009 00.000 00.000 00.00 Completed Startup
2. Early Stage VC (Series A) 25-Feb-2008 $1.27M $1.27M 00.000 Completed Startup
1. Grant Completed Startup
To view NeoSync’s complete valuation and funding history, request access »

NeoSync Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series C 00,000,000 00.000000 00.00 00.00 00 00.00 00.00
Series B 1,264,722 $0.001000 $0.06 $0.93 $0.93 1x $0.93 3.87%
Series A 2,385,415 $0.001000 0.04% $0.6 $0.6 1x $0.6 7.29%
To view NeoSync’s complete cap table history, request access »

NeoSync Patents

NeoSync Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-8585568-B2 Systems and methods for neuro-eeg synchronization therapy Active 12-Nov-2009 000000000 00
US-10821293-B2 Systems and methods for neuro-eeg synchronization therapy Active 12-Nov-2009 000000000
US-20170120066-A1 Systems and methods for neuro-eeg synchronization therapy Granted 12-Nov-2009 000000000 0
US-10065048-B2 Systems and methods for neuro-eeg synchronization therapy Active 12-Nov-2009 000000000 0
US-20140179980-A1 Systems and methods for neuro-eeg synchronization therapy Granted 12-Nov-2009 A61N2/008 00

NeoSync Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Medical University of South Carolina Foundation Limited Partner 000 0000 000000 0
Valiance PE/Buyout Minority 000 0000 000000 0
To view NeoSync’s complete investors history, request access »